Day: March 24, 2026

CephX Announces FDA Clearance for 3D Imaging and Expands Global AI Imaging Ecosystem with Integrations into DEXIS and Greyfinch

March 24, 2026

DOVER, Del., March 24, 2026 /PRNewswire/ — Orca Dental AI, the global leader in AI-powered orthodontic imaging solutions and creator of the CephX platform, today announced it has received FDA clearance for 3D imaging, marking a major milestone in the company’s mission to bring advanced AI-powered diagnostic support into everyday clinical workflows.

LiviWell Secures FDA Clearance for Livi, Introducing a New Category in Post-Intercourse Vaginal Care

March 24, 2026

MOUNTAIN LAKES, N.J., March 24, 2026 /PRNewswire/ — LiviWell, a women’s health company dedicated to developing innovative solutions for intimate health, today announced that the U.S. Food and Drug Administration (FDA) has cleared Livi, a first-of-its-kind device designed to support vaginal health by absorbing semen and other post-intercourse fluids.

Air-sampling tunnel reveals major person-to-person differences in release of infectious virus

March 24, 2026

The findings help explain why some people appear far more likely than others to transmit respiratory viruses and offer new insight into how influenza spreads through the air.

Surgical stitches could release anti-inflammatory drugs at wound sites for weeks

March 24, 2026

Researchers at Ouachita Baptist University are creating stitches loaded with anti-inflammatory drugs to deliver the medication directly to the injury.

Blog

- March 24, 2026

CephX Announces FDA Clearance for 3D Imaging and Expands Global AI Imaging Ecosystem with Integrations into DEXIS and Greyfinch

LiviWell Secures FDA Clearance for Livi, Introducing a New Category in Post-Intercourse Vaginal Care

Air-sampling tunnel reveals major person-to-person differences in release of infectious virus

Surgical stitches could release anti-inflammatory drugs at wound sites for weeks